Gonzalo Herradón obtained his PhD in pharmacology at the Faculty of Pharmacy of the University CEU San Pablo (2003). In 2002, Dr. Herradón joined as a Research Investigator the neurobiology department at Millennium Pharmaceuticals, Inc (Cambridge, MA, USA) to work in new strategies to identify novel genes involved in the development and maintenance of neuropathic pain. In 2003, he started a 3-year postdoctoral stay in the lab of Dr. Thomas F. Deuel at The Scripps Research Institute (La Jolla, CA, USA). In 2006, Dr. Herradón returned to the Faculty of Pharmacy at the University CEU San Pablo in Madrid (Spain). In 2007, he became the coordinator of the bilingual program of Pharmacy CEU-University of Chicago and Associate Professor of Pharmacology. Since 2007, he has directed three consecutive research projects aiming to dissect the possible roles of midkine and pleiotrophin in drug addiction, pain transmission and Parkinson’s disease. In 2011 Dr. Herradón received the Award from the Royal National Academy of Pharmacy of Spain to the best research work in opioids and pain transmission, and he became Full Professor of Pharmacology at The University CEU San Pablo.
Biography Updated on 12 August 2012